A mouse model of galactose-1-phosphate uridyl transferase deficiency

Biochemical and Molecular Medicine

Volumn 59, Issue 1, 1996, Pages 7-12

  Leslie, Nancy D ^a   Yager, Karen L ^a   McNamara, Pamela D ^b   Segal, Stanton ^b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; ENZYME DEFICIENCY; GALACTOSEMIA; GENE TARGETING; MOUSE; NONHUMAN;

ANIMALIA;

EID: 0030273135     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.0057     Document Type: Article

References (18)

1. 1. Segal S, Berry G. Disorders of galactose metabolism. In The Metabolic and Molecular Basis of Inherited Disease (Scriver CR, Beaudet AL, Sly WS, Vall D, Eds.) McGraw-Hill, New York, 1995, pp. 967-1000.
2. 2. Waggoner D, Buist N, Donnell G. Long-term prognosis in galactosaemia: Results of a survey of 350 cases. J Inher Metab Dis 13:802-818, 1990.
3. 3. Segal, S. Galactosemia unsolved. Eur J Pediatr 154:S97-S102, 1995.
4. 4. Leslie ND, Immerman EB, Flach JE, Florez M, Fridovich-Keil JL, Elsas LJ. The human galactose-1-phosphate uridyl transferase gene. Genomics 14:474-480, 1992.
5. 5. Reid LH, Gregg RG, Smithies O, Koller BH. Regulatory elements in the intron of the human HPRT gene are necessary for its expression in embryonic stem cells. Proc Natl Acad Sci USA 87:4299-4303, 1990.
6. 6. Doetschman T. Gene transfer in embryonic stem cells. In Transgenic Animal Technology (Pinkert CA, Ed.), Academic Press, San Diego, 1994, pp. 115-146.
7. 7. Bertoli D, Segal S. Developmental aspects and some characteristics of mammalian galactose-1-phosphate uridyltransferase. J Biol Chem 241:4023-4029, 1966.
8. 8. Pesce MA, Bodourian SH, Nicholson JF. A new microfluorometric method for the measurement of galactose-1-phosphate in erythrocytes. Clin Chim Acta 118:177-189, 1982.
9. 9. Berry GT, Palmieri M, Gross KC, Acosta PB, Henstenburg JA, Mazur AT, Reynolds R, Segal S. The effect of dietary fruits and vegetables on urinary galactitol excretion in galactose-1-phosphate uridyl transferase deficiency. J Inher Metab Dis 16:91-100, 1993.
10. 10. Field TL, Reznikoff WS, Frey PA. Galactose-1-phosphate uridylyltransferase: Identification of histidine-164 and histidine-166 as critical residues by site-directed mutagenesis. Biochemistry 28:2094-2099, 1989.
11. 11. Gitzelmann, R. Galactose-1-phosphate in the pathophysiology of galactosemia. Eur J Pediatr 154:545-549, 1995.
12. 12. Holton JB. Effects of galactosemia in utero. Eur J Pediatr 154:S77-S81, 1995.
13. 13. Jakobs C, Schweitzer S, Dorland B. Galactitol in galactosemia. Eur J Pediatr 154:S50-S52, 1995.
14. 14. Lee AYW, Chung SK, Chung SSM. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA 92:2780-2784, 1995.
15. 15. Yamaoka T, Nishimura C, Yamashita K, Itakura M, Yamada T, Fujimoto J, Koka Y. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia 38:255-261, 1995.
16. 16. Ragueneau R. Early development in mice IV: Quantity and gross composition of milk in five inbred strains. Physiol Behav 40:431-435, 1987.
17. 17. Berry GT, Nissim I, Li Z, Mazur AT, Gibson JB, Segal S. Endogenous synthesis of galactose in normal man and patients with hereditary galactosemia. Lancet 346:1073-1074, 1995.
18. 14 galactose by patients with congenital galactosemia: Evidence for a direct oxidative pathway. Am J Med 44:340-347, 1968.